The US Special Operations Command (SOCOM) has partnered with tech firm Seerist to enhance its capabilities through artificial intelligence (AI) and machine learning. This five-year cooperative agreement aims to improve global event detection, risk assessment, and operational decision-making, using AI-powered analytics for better information gathering, situational awareness, and prediction of emerging threats. Seerist’s models utilize open-source data, including news, social media, weather, and economic indicators, to automate analysis and provide timely insights. This initiative represents a significant step in modernizing national security efforts, with Seerist Federal President John Goolgasian emphasizing the importance of integrating AI-driven intelligence to enable faster, more informed responses in complex environments.
Meanwhile, the US has been actively investing in AI for military applications. Since 2018, DARPA has allocated $2 billion to about 20 projects focusing on transforming computers from specialized tools into problem-solving partners. Recently, Romania’s OVES Enterprise was tasked with integrating AI into its EAGLS counter-drone system, and the US Air Force successfully conducted a 17-hour flight of the VISTA X-62A tactical aircraft using an AI agent for beyond-visual-range engagements. These efforts illustrate how AI is increasingly embedded into defense systems, enhancing operational readiness and response capabilities.
In the medical field, Olympus showcased its latest AI-powered endoscopy solutions at the Digestive Disease Week (DDW) meeting in San Diego. The Olympus OLYSENSE Platform featuring the CADDIE device uses cloud-based AI to assist gastroenterologists in detecting suspected polyps during colonoscopy—an advancement that could significantly improve early diagnosis and treatment. Olympus’s technology portfolio also includes visualization tools like the ENDOCUFF Vision and imaging enhancements such as TXI technology, along with a range of hemostasis products for advanced procedures. Additionally, their new EU-ME3 ultrasound processor supports lesion detection and characterization, further advancing endoscopic diagnostics.
Celebrated physicians and specialists presented and discussed these innovations at DDW, emphasizing the integration of AI in clinical practice. Olympus’s commitment to innovation was highlighted through various educational sessions, and the company’s solutions are aimed at elevating care and improving patient outcomes globally. Olympus’s long-standing aim of contributing to society through technological innovation continues to shape the future of healthcare.
,
- 0 Comments
- AI-powered analytics
- DDW
- endoscopy
- Olympus